| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/18/2011 | CN101404996B Composition containing lignan compound |
| 05/18/2011 | CN101401787B Ceftiofur long-acting injection and preparation method thereof |
| 05/18/2011 | CN101396528B Traditional Chinese medicine composite preparation for treating wind-heat cold |
| 05/18/2011 | CN101390830B Anarexol cream and preparation method thereof |
| 05/18/2011 | CN101380393B Ointment for treating pharyngitis and preparation method thereof |
| 05/18/2011 | CN101361772B Oral medicine for treating traumatic injury and production method thereof |
| 05/18/2011 | CN101361725B External preparation containing phentolamine and preparation method thereof |
| 05/18/2011 | CN101317873B Hyperosteogeny ache-reliving plaster and preparation method thereof |
| 05/18/2011 | CN101293085B Umbilicus plaster powder for chronic bronchitis |
| 05/18/2011 | CN101288700B Chinese medicinal composition and preparation method and detection method thereof |
| 05/18/2011 | CN101288686B Health preparation for increasing bone density and preparation method thereof |
| 05/18/2011 | CN101284042B Glycyrrhiza extract for alleviating cardiotoxicity of medicine and application |
| 05/18/2011 | CN101278929B Method for preparing medicament containing gambogic acid compounds and clathrate of gambogic acid compounds |
| 05/18/2011 | CN101274050B Application of rhizome of Common Burreed in preparation of medicament for curing virosis |
| 05/18/2011 | CN101259290B Target tumor intervention therapeutic agent, its preparation and application |
| 05/18/2011 | CN101259158B Chinese medicine pharmaceutical composition for treating coronary heart disease and preparation |
| 05/18/2011 | CN101214298B Externally-applied pharmaceutical composition for treating mazopathy |
| 05/18/2011 | CN101209341B Chinese medicinal preparation, preparation and detection method thereof |
| 05/18/2011 | CN101209324B 'Penqiangjin' capsule |
| 05/18/2011 | CN101204508B Liquid Chinese traditional medicine capsule and preparation method thereof |
| 05/18/2011 | CN101203553B Porous cellulose aggregate and molding composition thereof |
| 05/18/2011 | CN101167726B Rosiglitazone maleate dispersible tablet and preparation method thereof |
| 05/18/2011 | CN101164619B Pyritinol injection with special purpose solvent |
| 05/18/2011 | CN101129972B Traditional Chinese medicine composition, preparation method and use of the same |
| 05/18/2011 | CN101129441B Rhodiola rosea capsule and its preparing method |
| 05/18/2011 | CN101125158B Traditional Chinese medicine patch for treating infantile diarrhea and preparation method thereof |
| 05/18/2011 | CN101015527B Dropping pills preparation |
| 05/18/2011 | CN101014320B Composition of treatment of endobronchial infections |
| 05/17/2011 | US7943765 Preparing biodegradable plastics for use as surgical tools; cosmetics; pollution control |
| 05/17/2011 | US7943695 Magnetic polymer particle, method of producing the same, and aqueous dispersion, cartridge, and image forming apparatus using the same |
| 05/17/2011 | US7943585 Extended release antibiotic composition |
| 05/17/2011 | US7943575 Sustained release drug formulations containing a carrier peptide |
| 05/17/2011 | US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943292 Physiologically acceptable aqueous solutions and methods for their use |
| 05/17/2011 | US7943181 Natural immunostimulant compositions, methods for obtaining the same and pharmaceutical formulations thereof |
| 05/17/2011 | US7943179 Drug delivery particle; useful in genetic vaccination; eg poly(beta-amino esters) |
| 05/17/2011 | US7943178 Methods and compositions for delivering peptides |
| 05/17/2011 | US7943177 Polyamide porous spherical particle |
| 05/17/2011 | US7943176 Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 05/17/2011 | US7943175 A dispersible colloid of nanoparticles of amphiphilically modified calixarene as carrier for an acitive material dispersed in water; compatible with medical, biological, veterinary, cosmetic and alimentary uses; side effect reduction; nontoxic; Foods and beverages; phytosanitary products; drug delivery |
| 05/17/2011 | US7943174 Controlled release hydrocodone formulations |
| 05/17/2011 | US7943173 Pharmaceutical combinations of oxycodone and naloxone |
| 05/17/2011 | US7943172 Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound |
| 05/17/2011 | US7943171 Use of branched malto-dextrins as granulation binders |
| 05/17/2011 | US7943170 immediate release phase and a sustained release phase of paracetamol, which has a unique in vitro dissolution profile; suitable for treating both acute pain such as dental pain or headache and chronic pain, such as the pain associated with arthritis. |
| 05/17/2011 | US7943169 At least one herbal or homeopathic active agent and a pharmaceutically acceptable solid bioadhesive carrier |
| 05/17/2011 | US7943168 liquid hydrophobic core coated with a lipid/surfactant layer which contains the peptides; melittin |
| 05/17/2011 | US7943167 Compositions with hydrophilic drugs in a hydrophobic medium |
| 05/17/2011 | US7943166 transient receptor potential vanilloid-1 (TRPV1) such as capsaicin; for reducing nociceptive nerve fiber function; topical application |
| 05/17/2011 | US7943165 Saline nose wipe and methods of manufacture and use |
| 05/17/2011 | US7943162 Body having an internal surface for disposing on a target tissue and a well having an opening to the internal surface; inner core with drug containing portion and an expandable material such as hydrogel in the well; delivery drugs such as eliprodil to the eye for example |
| 05/17/2011 | US7943158 Soil is treated with biofilms containing molecular iodine in vapor or dissolved liquid form |
| 05/17/2011 | US7943155 Self-reversible reverse microlatex process for preparing it and cosmetic and industrial uses thereof |
| 05/17/2011 | US7943154 Method for producing multiple emulsions that are stable in storage |
| 05/17/2011 | US7943118 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 05/17/2011 | US7943067 Nanogels and their production using liposomes as reactors |
| 05/17/2011 | US7943065 Conductive carbon nanotube-polymer composite |
| 05/17/2011 | US7942867 Remotely controlled substance delivery device |
| 05/17/2011 | US7942846 Needleless syringe using supersonic gas flow for particle delivery |
| 05/17/2011 | US7942147 Aerosol forming device for use in inhalation therapy |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2589549C System for improved percutaneous absorption of skin benefiting agents |
| 05/17/2011 | CA2496763C Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 05/17/2011 | CA2493496C Antiaging composition |
| 05/17/2011 | CA2490157C Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 05/17/2011 | CA2479919C Powder formulations suitable for inhalation |
| 05/17/2011 | CA2479735C Fast dissolving dosage forms having reduced friability |
| 05/17/2011 | CA2466525C Synthesis of small particles |
| 05/17/2011 | CA2425489C Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 05/17/2011 | CA2422580C Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 05/17/2011 | CA2420597C Milled particles |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2394717C Iron chelator delivery system |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/17/2011 | CA2376339C Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 05/12/2011 | WO2011057266A2 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing |
| 05/12/2011 | WO2011057235A2 Improved delivery of submicrometer and nonometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery |
| 05/12/2011 | WO2011057224A2 Zwitterionic polymer bioconjugates and related methods |
| 05/12/2011 | WO2011057216A1 Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo |
| 05/12/2011 | WO2011057206A1 Cellulose capsules and methods for making them |
| 05/12/2011 | WO2011057134A1 Generation of antigenic virus-like particles through protein-protein linkages |
| 05/12/2011 | WO2011057133A1 Fragmented hydrogels |
| 05/12/2011 | WO2011057131A1 Polysaccharide based hydrogels |
| 05/12/2011 | WO2011057108A1 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 05/12/2011 | WO2011056978A2 S isomers of alpha-methyl hydrocinnamic acid for the treatment of blood disorders |
| 05/12/2011 | WO2011056889A1 An apparatus and method for simulating inhalation efforts |
| 05/12/2011 | WO2011056829A1 An oral vaccine to protect animals against plague |
| 05/12/2011 | WO2011056793A2 Composition, method, and kit for alpha-1 proteinase inhibitor |
| 05/12/2011 | WO2011056785A2 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| 05/12/2011 | WO2011056775A2 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| 05/12/2011 | WO2011056773A2 Inhibiting neurotransmitter reuptake |
| 05/12/2011 | WO2011056741A2 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 05/12/2011 | WO2011056702A2 Fast dissolving/disintegrating coating compositions |
| 05/12/2011 | WO2011056682A1 Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids |
| 05/12/2011 | WO2011056667A2 Rosacea topical skin treatment method and formulation |
| 05/12/2011 | WO2011056653A2 Clonidine formulations having antimicrobial properties |
| 05/12/2011 | WO2011056545A2 Antimicrobial ionic liquids |
| 05/12/2011 | WO2011056487A2 Stable thickener formulations |
| 05/12/2011 | WO2011056382A1 Angiogenesis promoted by caged growth factors |